Saturday 17 October 2026 Export MRVI’s income statement to Excel — free account

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.53%, EPS grew 70.4%, free cash flow grew 127.6% and total debt fell 45.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.79 0.28 −3.96%

Follow MRVI

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −16.2×
Dividend yield: —
F-score: 2/9
Altman Z: 0.44
Beneish M: −3.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		2.16	2.53	2.02	4.42
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(27.41)	(20.61)	47.82	231.34
P/B ratio Full definition →		0.96	1.26	1.12	2.60
Price to Tangible BV Full definition →		3.56	5.11	4.37	10.52
EV/Sales Full definition →		2.57	3.09	2.54	4.93
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(10.01)	(9.97)	(13.14)	(40.78)
EV/FCF Full definition →		(7.46)	(8.12)	(9.87)	(28.74)
Quick Ratio Full definition →		4.32	5.40	4.68	2.63
Current Ratio Full definition →		5.29	6.60	5.91	4.05
Net Debt/EBITDA Full definition →		4.29	(1.21)	9.70	(63.38)
Debt/Assets Full definition →		38.06%	41.78%	37.98%	29.27%
Debt/Equity Full definition →		0.75	0.86	0.73	0.50
Asset Turnover Full definition →		0.18	0.21	0.24	0.28
Operating CF/Net income Full definition →		0.59	0.64	(2.32)	(0.32)
Capex/Depreciation Full definition →		(0.06)	0.08	(0.34)	(0.03)
Interest Coverage Full definition →		(6.00)	(8.97)	(0.38)	(3.14)
Research and Development Expense of Revenue Full definition →		9.23%	7.60%	5.91%	7.20%
Selling, General and Administrative Expense of Revenue Full definition →		85.03%	63.05%	44.19%	62.34%
Intangible Assets out of Total Assets Full definition →		0.37	0.36	0.38	0.44
Share Based Compensation of Revenue Full definition →		21.75%	7.87%	10.24%	19.84%
Graham Net Nets Full definition →		(0.22)	(0.22)	(0.22)	(0.10)
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(29.27%)	(27.69%)	(25.09%)	(8.33%)
Free Cash Flow Yield Full definition →		(15.97%)	(15.07%)	(12.69%)	(3.88%)
Revenue per Share Full definition →		0.29	0.35	0.45	0.35
Operating CF per Share Full definition →		(0.10)	(0.16)	0.06	0.03
Capex per Share Full definition →		(0.03)	(0.01)	(0.03)	0.00
Free Cash Flow per Share Full definition →		(0.13)	(0.17)	0.03	0.02
Cash per Share Full definition →		1.68	1.50	1.13	0.47
Shareholders Equity per Share Full definition →		2.98	2.58	2.52	2.40
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		2.98	2.58	2.52	2.40
Free Cash Flow Full definition →		(18.81)	(24.88)	4.23	3.62
Working Capital Full definition →		264.29	251.33	209.11	117.24
Capital Expenditures Full definition →		(3.66)	(2.11)	(4.44)	(0.37)
Net Current Asset Value Full definition →		(91.46)	(101.61)	(92.40)	(92.50)
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.09	0.04	0.07	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		25.71	32.01	30.95	29.51
Average Payables Full definition →		8.75	7.43	9.03	9.33
Average Inventory Full definition →		47.87	45.29	45.12	43.95
Average Assets Full definition →		1,063.70	889.41	836.48	750.36
Average Common Equity Full definition →		522.49	474.96	449.68	411.79

Fold the line items

Columns are period end dates

Stockrow Weekly